Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia

Jennifer L. Whitwell, Joseph R. Duffy, Edythe A. Strand, Mary M. Machulda, Matthew L. Senjem, Christopher G. Schwarz, Robert Reid, Matthew C. Baker, Ralph B. Perkerson, Val J. Lowe, Rosa Rademakers, Clifford R. Jack, Keith A. Josephs

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Logopenic primary progressive aphasia (lvPPA) is a progressive language disorder characterized by anomia, difficulty repeating complex sentences, and phonological errors. The majority, although not all, lvPPA patients have underlying Alzheimer's disease. We aimed to determine whether clinical or neuroimaging features differ according to the deposition of Aβ on Pittsburgh-compound B PET in lvPPA. Clinical features, patterns of atrophy on MRI, hypometabolism on FDG-PET, and white matter tract degeneration were compared between six PiB-negative and 20 PiB-positive lvPPA patients. PiB-negative patients showed more asymmetric left-sided patterns of atrophy, hypometabolism and white matter tract degeneration, with greater left anteromedial temporal and medial prefrontal involvement, than PiB-positive patients. PiB-positive patients showed greater involvement of right temporoparietal and frontal lobes. There was very little evidence for clinical differences between the groups. Strikingly asymmetric neuroimaging findings with relatively preserved right hemisphere may provide clues that AD pathology is absent in lvPPA.

Original languageEnglish (US)
Pages (from-to)45-53
Number of pages9
JournalBrain and Language
Volume142
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Primary Progressive Aphasia
speech disorder
Amyloid
Neuroimaging
Biomarkers
dementia
pathology
Atrophy
Anomia
Language Disorders
language
evidence
Frontal Lobe
Group
Alzheimer Disease
Pathology

Keywords

  • Beta-amyloid
  • FDG-PET
  • Logopenic
  • Magnetic resonance imaging
  • Pittsburgh compound B
  • Primary progressive aphasia
  • Progranulin

ASJC Scopus subject areas

  • Language and Linguistics
  • Experimental and Cognitive Psychology
  • Linguistics and Language
  • Cognitive Neuroscience
  • Speech and Hearing

Cite this

Whitwell, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Schwarz, C. G., ... Josephs, K. A. (2015). Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia. Brain and Language, 142, 45-53. https://doi.org/10.1016/j.bandl.2015.01.009

Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia. / Whitwell, Jennifer L.; Duffy, Joseph R.; Strand, Edythe A.; Machulda, Mary M.; Senjem, Matthew L.; Schwarz, Christopher G.; Reid, Robert; Baker, Matthew C.; Perkerson, Ralph B.; Lowe, Val J.; Rademakers, Rosa; Jack, Clifford R.; Josephs, Keith A.

In: Brain and Language, Vol. 142, 01.03.2015, p. 45-53.

Research output: Contribution to journalArticle

Whitwell, JL, Duffy, JR, Strand, EA, Machulda, MM, Senjem, ML, Schwarz, CG, Reid, R, Baker, MC, Perkerson, RB, Lowe, VJ, Rademakers, R, Jack, CR & Josephs, KA 2015, 'Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia', Brain and Language, vol. 142, pp. 45-53. https://doi.org/10.1016/j.bandl.2015.01.009
Whitwell, Jennifer L. ; Duffy, Joseph R. ; Strand, Edythe A. ; Machulda, Mary M. ; Senjem, Matthew L. ; Schwarz, Christopher G. ; Reid, Robert ; Baker, Matthew C. ; Perkerson, Ralph B. ; Lowe, Val J. ; Rademakers, Rosa ; Jack, Clifford R. ; Josephs, Keith A. / Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia. In: Brain and Language. 2015 ; Vol. 142. pp. 45-53.
@article{97605db4e47d40aeb93fcd7cae78cc26,
title = "Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia",
abstract = "Logopenic primary progressive aphasia (lvPPA) is a progressive language disorder characterized by anomia, difficulty repeating complex sentences, and phonological errors. The majority, although not all, lvPPA patients have underlying Alzheimer's disease. We aimed to determine whether clinical or neuroimaging features differ according to the deposition of Aβ on Pittsburgh-compound B PET in lvPPA. Clinical features, patterns of atrophy on MRI, hypometabolism on FDG-PET, and white matter tract degeneration were compared between six PiB-negative and 20 PiB-positive lvPPA patients. PiB-negative patients showed more asymmetric left-sided patterns of atrophy, hypometabolism and white matter tract degeneration, with greater left anteromedial temporal and medial prefrontal involvement, than PiB-positive patients. PiB-positive patients showed greater involvement of right temporoparietal and frontal lobes. There was very little evidence for clinical differences between the groups. Strikingly asymmetric neuroimaging findings with relatively preserved right hemisphere may provide clues that AD pathology is absent in lvPPA.",
keywords = "Beta-amyloid, FDG-PET, Logopenic, Magnetic resonance imaging, Pittsburgh compound B, Primary progressive aphasia, Progranulin",
author = "Whitwell, {Jennifer L.} and Duffy, {Joseph R.} and Strand, {Edythe A.} and Machulda, {Mary M.} and Senjem, {Matthew L.} and Schwarz, {Christopher G.} and Robert Reid and Baker, {Matthew C.} and Perkerson, {Ralph B.} and Lowe, {Val J.} and Rosa Rademakers and Jack, {Clifford R.} and Josephs, {Keith A.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.bandl.2015.01.009",
language = "English (US)",
volume = "142",
pages = "45--53",
journal = "Brain and Language",
issn = "0093-934X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia

AU - Whitwell, Jennifer L.

AU - Duffy, Joseph R.

AU - Strand, Edythe A.

AU - Machulda, Mary M.

AU - Senjem, Matthew L.

AU - Schwarz, Christopher G.

AU - Reid, Robert

AU - Baker, Matthew C.

AU - Perkerson, Ralph B.

AU - Lowe, Val J.

AU - Rademakers, Rosa

AU - Jack, Clifford R.

AU - Josephs, Keith A.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Logopenic primary progressive aphasia (lvPPA) is a progressive language disorder characterized by anomia, difficulty repeating complex sentences, and phonological errors. The majority, although not all, lvPPA patients have underlying Alzheimer's disease. We aimed to determine whether clinical or neuroimaging features differ according to the deposition of Aβ on Pittsburgh-compound B PET in lvPPA. Clinical features, patterns of atrophy on MRI, hypometabolism on FDG-PET, and white matter tract degeneration were compared between six PiB-negative and 20 PiB-positive lvPPA patients. PiB-negative patients showed more asymmetric left-sided patterns of atrophy, hypometabolism and white matter tract degeneration, with greater left anteromedial temporal and medial prefrontal involvement, than PiB-positive patients. PiB-positive patients showed greater involvement of right temporoparietal and frontal lobes. There was very little evidence for clinical differences between the groups. Strikingly asymmetric neuroimaging findings with relatively preserved right hemisphere may provide clues that AD pathology is absent in lvPPA.

AB - Logopenic primary progressive aphasia (lvPPA) is a progressive language disorder characterized by anomia, difficulty repeating complex sentences, and phonological errors. The majority, although not all, lvPPA patients have underlying Alzheimer's disease. We aimed to determine whether clinical or neuroimaging features differ according to the deposition of Aβ on Pittsburgh-compound B PET in lvPPA. Clinical features, patterns of atrophy on MRI, hypometabolism on FDG-PET, and white matter tract degeneration were compared between six PiB-negative and 20 PiB-positive lvPPA patients. PiB-negative patients showed more asymmetric left-sided patterns of atrophy, hypometabolism and white matter tract degeneration, with greater left anteromedial temporal and medial prefrontal involvement, than PiB-positive patients. PiB-positive patients showed greater involvement of right temporoparietal and frontal lobes. There was very little evidence for clinical differences between the groups. Strikingly asymmetric neuroimaging findings with relatively preserved right hemisphere may provide clues that AD pathology is absent in lvPPA.

KW - Beta-amyloid

KW - FDG-PET

KW - Logopenic

KW - Magnetic resonance imaging

KW - Pittsburgh compound B

KW - Primary progressive aphasia

KW - Progranulin

UR - http://www.scopus.com/inward/record.url?scp=84961290470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961290470&partnerID=8YFLogxK

U2 - 10.1016/j.bandl.2015.01.009

DO - 10.1016/j.bandl.2015.01.009

M3 - Article

VL - 142

SP - 45

EP - 53

JO - Brain and Language

JF - Brain and Language

SN - 0093-934X

ER -